Toshio Fujino

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Small Cell Lung Cancer

Aortic Valve Replacement

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Lung Cancer (Auckland, N.Z.)

Clinical cancer research : an official journal of the American Association for Cancer Research

Surgical case reports

Expert opinion on emerging drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Jessica J Lin, Joshua C Horan, Anupong Tangpeerachaikul, Aurélie Swalduz, Augusto Valdivia, Melissa Lynne Johnson, Benjamin Besse, D Ross Camidge, Toshio Fujino, Satoshi Yoda, Linh Nguyen-Phuong, Hayato Mizuta, Ludovic Bigot, Catline Nobre, Jii Bum Lee, Mi Ra Yu, Scot Mente, Yuting Sun, Nancy E Kohl, James R Porter, Matthew D Shair, Viola W Zhu, Enriqueta Felip Font, Byoung Chul Cho, Luc Friboulet, Aaron N Hata, Henry E Pelish, Alexander E Drilon
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations. Cancer discovery (2024)
Sun Min Lim, Toshio Fujino, Chulwon Kim, Gwanghee Lee, Yong-Hee Lee, Dong Wan Kim, Jin Seok Ahn, Tetsuya Mitsudomi, Taiguang Jin, Sang-Yoon Lee
BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Toshio Fujino, Kenichi Suda, Tetsuya Mitsudomi
Lung Cancer with MET exon 14 Skipping Mutation: Genetic Feature, Current Treatments, and Future Challenges. Lung Cancer (Auckland, N.Z.) 12 (2021)
Toshio Fujino, Kenichi Suda, Tetsuya Mitsudomi
Emerging MET tyrosine kinase inhibitors for the treatment of non-small cell lung cancer. Expert opinion on emerging drugs 25 (3) (2020)
Toshio Fujino, Masayuki Tanahashi, Haruhiro Yukiue, Eriko Suzuki, Naoko Yoshii, Masayuki Shitara, Yasunori Kaminuma, Hiroshi Niwa
A new approach to left sleeve pneumonectomy: complete VATS left pneumonectomy followed by right thoracotomy for carinal resection and reconstruction. Surgical case reports 4 (1) (2018)